Search Results

Vascular Surgery Continues to Seek Specialty Status

Endovascular Today interviews ISVS President, Sir Peter R.F. Bell, MD, regarding the issues slowing the progress of separate board certification.

By Sir Peter R.F. Bell, MD

Acute Limb Ischemia Surgical Options

Can a surgical approach achieve a higher limb salvage rate, or is thrombolysis a safer and less invasive procedure?

By Ian Loftus, MD, and Peter R.F. Bell, MD

An Interview With Enrico Ascher, MD

The current president of the ISVS discusses the society's goals, his research interests, and improving results for the academic surgical community.

When Is Surgery Still the Best Option?

Given the variety of endovascular treatment modalities for lower-leg interventions, when should physicians consider surgical treatment in their patient management?

By Panagiotis Kougias, MD; Wei Zhou, MD; Alan B. Lumsden, MD; and Peter H. Lin, MD

Top Tips in Interventional Oncology

Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.

By Siddharth A. Padia, MD; Theodore Bryan, MD; Rebecca Bennett, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Raul N. Uppot, MD; Robert Suh, MD; Paul I. Mallinson, MBChB, FRCR, FRCPC; Peter L. Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon); Miyuki Sone, MD; and Yasuaki Arai, MD, FSIR, FCIRSE

Successful Endovenous Ablation

Is it the technology or the technique?

By Steve Elias, MD, with Jose I. Almeida, MD; Peter Gloviczki, MD; Nick Morrison, MD; and Julianne Stoughton, MD

Novel Therapies for CLI Revascularization and Management

Innovative modalities on the horizon for the treatment of critical limb ischemia.

By J.A. Mustapha, MD; Fadi Saab, MD; and Sara Finton, BSN

The Future of Biomarkers in Interventional Oncology

Personalized therapies targeting specific biomarkers and cancer genomics are bringing new hope in the management of cancer.

By Samuel L. Rice, MD, and Constantinos T. Sofocleous, MD, PhD

Study Finds Large Interhospital Variability for CLTI Revascularization

With Aishwarya Raja, MD; Fadi Saab, MD, FACC, FASE, FSCAI; and Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

Resistant Hypertension: Clinical Considerations and the Potential for Renal Denervation

The current landscape of major clinical trials and treatment.

By Vikas Kapil, MD, MRCP, PhD, and Melvin D. Lobo, MD, FRCP, PhD